Zidovudine
4 NDCs across 2 manufacturers|4 Generic,0 Brand
Zidovudine is used to treat acquired immunodeficiency syndrome, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Mar 19, 1987, and the first generic was approved Sep 19, 2005. FDA's Orange Book lists 6 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $169K on Zidovudine across 2,642 claims for 398 beneficiaries.
Zidovudine is available as 4 NDCs from 2 manufacturers (4 generic, 0 brand), with NADAC prices from $0.40 to $1.37 per EA — the most expensive product costs about 3.4× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
4
4G / 0B
Manufacturers
2
competing in market
Price Spread
$0.40 – $1.37
per EA, 3 of 4 NDCs
7d Activity
avg +0.0% WoW · of 4 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Aurobindo Pharma Limited manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
2 manufacturers producing ZIDOVUDINE
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
ZIDOVUDINE 100 MG CAPSULE | $1.3658 per EA | — |
ZIDOVUDINE 300 MG TABLET | $0.4638 per EA | — |
ZIDOVUDINE 300 MG TABLET | $0.4016 per EA | — |
ZIDOVUDINE 50 MG/5 ML SYRUP | $0.1499 per ML | — |
Frequently Asked Questions
What is Zidovudine used to treat?
Zidovudine is used to treat acquired immunodeficiency syndrome, per the National Library of Medicine's MED-RT classification.
When did Zidovudine become available as a generic?
FDA approved the first generic Zidovudine (ANDA) on Sep 19, 2005. The Orange Book currently lists 6 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How much does Medicare spend on Zidovudine?
In 2024, Medicare Part D spent $169K on Zidovudine across 2,642 claims for 398 beneficiaries.
How many Zidovudine products are on the market?
The Zidovudine drug market contains 4 NDCs from 2 manufacturers — 4 generic and 0 brand products.
What is the price range for Zidovudine?
NADAC reference prices for Zidovudine range from $0.4016 to $1.3658 per EA — the most expensive product costs about 3.4× the cheapest. 1 additional product is priced per a different unit (e.g. liquids per ML) and isn't directly comparable.
Which manufacturers make Zidovudine?
2 manufacturers list Zidovudine in NADAC. Ranked by number of NDCs, the largest are Aurobindo Pharma Limited (3), Camber Pharmaceuticals Inc. (1).